Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

Tesz GJ, Aouadi M, Prot M, Nicoloro SM, Boutet E, Amano SU, Goller A, Wang M, Guo CA, Salomon WE, Virbasius JV, Baum RA, O'Connor MJ Jr, Soto E, Ostroff GR, Czech MP.

Biochem J. 2011 Jun 1;436(2):351-62. doi: 10.1042/BJ20110352.

PMID:
21418037
2.

Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.

Cohen JL, Shen Y, Aouadi M, Vangala P, Tencerova M, Amano SU, Nicoloro SM, Yawe JC, Czech MP.

Mol Pharm. 2016 Mar 7;13(3):964-978. doi: 10.1021/acs.molpharmaceut.5b00831. Epub 2016 Feb 11.

3.

Macrophage specific delivery of TNF-α siRNA complexed with β-1,3-glucan inhibits LPS-induced cytokine production in a murine acute hepatitis model.

Mochizuki S, Morishita H, Sakurai K.

Bioorg Med Chem. 2013 May 1;21(9):2535-42. doi: 10.1016/j.bmc.2013.02.035. Epub 2013 Mar 5.

PMID:
23523387
4.

Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials.

Wang Y, Tran KK, Shen H, Grainger DW.

Biomaterials. 2012 Nov;33(33):8540-7. doi: 10.1016/j.biomaterials.2012.07.039. Epub 2012 Sep 3.

5.

RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system.

Kim SW, Kim NY, Choi YB, Park SH, Yang JM, Shin S.

J Control Release. 2010 May 10;143(3):335-43. doi: 10.1016/j.jconrel.2010.01.009. Epub 2010 Jan 14.

PMID:
20079391
6.

Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.

Vader P, Crielaard BJ, van Dommelen SM, van der Meel R, Storm G, Schiffelers RM.

J Control Release. 2012 Jun 10;160(2):211-6. doi: 10.1016/j.jconrel.2011.09.080. Epub 2011 Sep 29.

PMID:
21983283
7.

Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.

Tagalakis AD, He L, Saraiva L, Gustafsson KT, Hart SL.

Biomaterials. 2011 Sep;32(26):6302-15. doi: 10.1016/j.biomaterials.2011.05.022. Epub 2011 May 31.

PMID:
21624650
8.

Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.

Hibbitts A, O'Mahony AM, Forde E, Nolan L, Ogier J, Desgranges S, Darcy R, MacLoughlin R, O'Driscoll CM, Cryan SA.

J Aerosol Med Pulm Drug Deliv. 2014 Dec;27(6):466-77. doi: 10.1089/jamp.2013.1045.

PMID:
24665866
9.

RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice.

Gutbier B, Kube SM, Reppe K, Santel A, Lange C, Kaufmann J, Suttorp N, Witzenrath M.

Pulm Pharmacol Ther. 2010 Aug;23(4):334-44. doi: 10.1016/j.pupt.2010.03.007. Epub 2010 Apr 1.

PMID:
20362688
10.

Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound.

Negishi Y, Endo Y, Fukuyama T, Suzuki R, Takizawa T, Omata D, Maruyama K, Aramaki Y.

J Control Release. 2008 Dec 8;132(2):124-30. doi: 10.1016/j.jconrel.2008.08.019. Epub 2008 Sep 7.

PMID:
18804499
11.

A novel siRNA validation system for functional screening of effective RNAi targets in mammalian cells and development of a derivative lentivirus delivery system.

Huang G, Gao Q, Zhao Y, Dong Z, Li T, Guan X, Jiang J.

Gene. 2015 Mar 10;558(2):278-86. doi: 10.1016/j.gene.2014.12.063. Epub 2014 Dec 28.

PMID:
25550051
12.

Macrophage internalization of fungal beta-glucans is not necessary for initiation of related inflammatory responses.

McCann F, Carmona E, Puri V, Pagano RE, Limper AH.

Infect Immun. 2005 Oct;73(10):6340-9.

13.

TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.

Keates AC, Fruehauf J, Xiang S, Li CJ.

Biotechnol Genet Eng Rev. 2008;25:113-27. Review.

PMID:
21412352
14.

Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.

Sajeesh S, Lee TY, Kim JK, Son DS, Hong SW, Kim S, Yun WS, Kim S, Chang C, Li C, Lee DK.

J Control Release. 2014 Dec 28;196:28-36. doi: 10.1016/j.jconrel.2014.09.016. Epub 2014 Sep 20.

PMID:
25251899
15.

A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.

Li X, Chen Y, Wang M, Ma Y, Xia W, Gu H.

Biomaterials. 2013 Jan;34(4):1391-401. doi: 10.1016/j.biomaterials.2012.10.072. Epub 2012 Nov 17.

PMID:
23164421
16.

Transfer of small interfering RNA by single-cell electroporation in cerebellar cell cultures.

Tanaka M, Yanagawa Y, Hirashima N.

J Neurosci Methods. 2009 Mar 30;178(1):80-6. doi: 10.1016/j.jneumeth.2008.11.025. Epub 2008 Dec 9.

PMID:
19114056
17.

Specifically targeted delivery of protein to phagocytic macrophages.

Yu M, Chen Z, Guo W, Wang J, Feng Y, Kong X, Hong Z.

Int J Nanomedicine. 2015 Mar 4;10:1743-57. doi: 10.2147/IJN.S75950. eCollection 2015.

18.

Binary and ternary complexes based on polycaprolactone-graft-poly (N, N-dimethylaminoethyl methacrylate) for targeted siRNA delivery.

Huang Y, Lin D, Jiang Q, Zhang W, Guo S, Xiao P, Zheng S, Wang X, Chen H, Zhang HY, Deng L, Xing J, Du Q, Dong A, Liang Z.

Biomaterials. 2012 Jun;33(18):4653-64. doi: 10.1016/j.biomaterials.2012.02.052. Epub 2012 Apr 3.

PMID:
22480869
19.

Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system.

McCarthy J, O'Neill MJ, Bourre L, Walsh D, Quinlan A, Hurley G, Ogier J, Shanahan F, Melgar S, Darcy R, O'Driscoll CM.

J Control Release. 2013 May 28;168(1):28-34. doi: 10.1016/j.jconrel.2013.03.004. Epub 2013 Mar 14.

PMID:
23500058
20.

Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.

Guo J, Cheng WP, Gu J, Ding C, Qu X, Yang Z, O'Driscoll C.

Eur J Pharm Sci. 2012 Apr 11;45(5):521-32. doi: 10.1016/j.ejps.2011.11.024. Epub 2011 Dec 11.

PMID:
22186295

Supplemental Content

Support Center